UBS Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,483,040
| Closed | -$4.51M | – | 9514 |
|
2024
Q4 | $4.51M | Buy |
1,483,040
+850,487
| +134% | +$2.59M | ﹤0.01% | 3075 |
|
2024
Q3 | $3.28M | Buy |
632,553
+581,780
| +1,146% | +$3.02M | ﹤0.01% | 2624 |
|
2024
Q2 | $130K | Sell |
50,773
-139,419
| -73% | -$358K | ﹤0.01% | 4855 |
|
2024
Q1 | $936K | Sell |
190,192
-3,961
| -2% | -$19.5K | ﹤0.01% | 3598 |
|
2023
Q4 | $1.71M | Buy |
194,153
+76,108
| +64% | +$669K | ﹤0.01% | 2990 |
|
2023
Q3 | $1.35M | Sell |
118,045
-11,980
| -9% | -$137K | ﹤0.01% | 2866 |
|
2023
Q2 | $3.29M | Sell |
130,025
-1,264
| -1% | -$32K | ﹤0.01% | 2251 |
|
2023
Q1 | $4.23M | Buy |
131,289
+58,464
| +80% | +$1.88M | ﹤0.01% | 1982 |
|
2022
Q4 | $1.34M | Sell |
72,825
-9,937
| -12% | -$183K | ﹤0.01% | 2895 |
|
2022
Q3 | $2.23M | Sell |
82,762
-4,147
| -5% | -$112K | ﹤0.01% | 2276 |
|
2022
Q2 | $1.2M | Sell |
86,909
-2,361
| -3% | -$32.6K | ﹤0.01% | 2756 |
|
2022
Q1 | $1.74M | Buy |
89,270
+4,615
| +5% | +$90K | ﹤0.01% | 2766 |
|
2021
Q4 | $1.38M | Buy |
84,655
+23,374
| +38% | +$381K | ﹤0.01% | 3185 |
|
2021
Q3 | $1.71M | Buy |
61,281
+8,099
| +15% | +$226K | ﹤0.01% | 2864 |
|
2021
Q2 | $1.58M | Sell |
53,182
-952
| -2% | -$28.2K | ﹤0.01% | 2914 |
|
2021
Q1 | $1.51M | Buy |
54,134
+6,140
| +13% | +$172K | ﹤0.01% | 3004 |
|
2020
Q4 | $1.36M | Sell |
47,994
-511
| -1% | -$14.5K | ﹤0.01% | 2926 |
|
2020
Q3 | $1.22M | Sell |
48,505
-4,648
| -9% | -$117K | ﹤0.01% | 2798 |
|
2020
Q2 | $1.3M | Buy |
53,153
+12,427
| +31% | +$303K | ﹤0.01% | 2619 |
|
2020
Q1 | $603K | Buy |
40,726
+11,476
| +39% | +$170K | ﹤0.01% | 3053 |
|
2019
Q4 | $474K | Buy |
29,250
+27,850
| +1,989% | +$451K | ﹤0.01% | 3938 |
|
2019
Q3 | $18K | Hold |
1,400
| – | – | ﹤0.01% | 5844 |
|
2019
Q2 | $18K | Buy |
1,400
+184
| +15% | +$2.37K | ﹤0.01% | 5821 |
|
2019
Q1 | $19K | Buy |
1,216
+768
| +171% | +$12K | ﹤0.01% | 5528 |
|
2018
Q4 | $9K | Sell |
448
-1,617
| -78% | -$32.5K | ﹤0.01% | 6371 |
|
2018
Q3 | $52K | Sell |
2,065
-1,383
| -40% | -$34.8K | ﹤0.01% | 5246 |
|
2018
Q2 | $95K | Buy |
3,448
+854
| +33% | +$23.5K | ﹤0.01% | 4602 |
|
2018
Q1 | $80K | Buy |
2,594
+214
| +9% | +$6.6K | ﹤0.01% | 4544 |
|
2017
Q4 | $85K | Buy |
2,380
+46
| +2% | +$1.64K | ﹤0.01% | 4539 |
|
2017
Q3 | $64K | Buy |
2,334
+1,823
| +357% | +$50K | ﹤0.01% | 4744 |
|
2017
Q2 | $13K | Buy |
511
+500
| +4,545% | +$12.7K | ﹤0.01% | 5666 |
|
2017
Q1 | $0 | Sell |
11
-1,041
| -99% | – | ﹤0.01% | 6871 |
|
2016
Q4 | $22K | Sell |
1,052
-844
| -45% | -$17.7K | ﹤0.01% | 5522 |
|
2016
Q3 | $31K | Buy |
1,896
+1,385
| +271% | +$22.6K | ﹤0.01% | 5028 |
|
2016
Q2 | $7K | Hold |
511
| – | – | ﹤0.01% | 6095 |
|
2016
Q1 | $9K | Sell |
511
-1,378
| -73% | -$24.3K | ﹤0.01% | 5884 |
|
2015
Q4 | $64K | Buy |
1,889
+1,389
| +278% | +$47.1K | ﹤0.01% | 4562 |
|
2015
Q3 | $15K | Hold |
500
| – | – | ﹤0.01% | 5680 |
|
2015
Q2 | $16K | Sell |
500
-157
| -24% | -$5.02K | ﹤0.01% | 5675 |
|
2015
Q1 | $13K | Sell |
657
-648
| -50% | -$12.8K | ﹤0.01% | 5716 |
|
2014
Q4 | $22K | Buy |
+1,305
| New | +$22K | ﹤0.01% | 5457 |
|